Analyst Report: EFX

1. EXECUTIVE SUMMARY

Equifax rose 16.05% over the week to a close of $187.14 on Thursday October 22, 2026, with the gain coming mainly from two sessions: an 11.33% jump on October 20 after third-quarter results, and a 6.59% rise on October 22 after an Argus upgrade to Buy. The earnings beat came with AI-driven cost savings running ahead of plan, which Pomegra says the market read as the main driver, and revenue grew 10% to $1.693bn. The week's first leg, a 7.25% rise on October 15, has no clear catalyst in the research. The S&P 500 fell 1.04% over the same period, so the move belongs to the company. Management cut its 2026 revenue midpoint and guided fourth-quarter revenue below expectations, so the rally rests on margins and sentiment recovery more than on top-line momentum. The shares remain 11.77% lower year to date.

2. THE CATALYST

October 20 (+11.33%, close $176.54, volume 3,986,100). Equifax reported before the open. According to the company press release and Investing.com, adjusted EPS was $2.26 against about $2.20 expected, and revenue of $1.693bn rose 10%. U.S. mortgage revenue rose 15% despite a weaker market, Diversified Markets grew 8% and USIS grew 13% (Equifax press release). Net income rose 32% to $211.7m (Investing.com). Pomegra said AI cost savings ahead of plan lifted margins excluding FICO, and Investing.com noted that pre-earnings downgrades had already been priced in.

The guidance offered a counterweight. TIKR reports that management cut its 2026 revenue midpoint to $6.661bn and guided fourth-quarter revenue to $1.605–1.635bn, below the roughly $1.68bn analysts wanted. Adjusted EPS guidance of $8.50 was kept.

October 22 (+6.59%, close $187.14, volume 2,741,300). TIKR and Yahoo Finance/TipRanks report that Argus upgraded the stock from Hold to Buy with a $200 target before the open. The thesis is that the data breach is behind the company, that growth is picking up as a new consumer credit-scoring model gains share, and that a double-digit dividend increase shows confidence. TIKR also reports that TransUnion rose by about the same amount with no news of its own, which points to sector sympathy buying (inference: the two moves are linked).

October 15 (+7.25%, close $161.26). The research found no clear catalyst. One weak source, Quiver Quant, links the rise to mortgage product launches on October 8 and October 13 and to pre-earnings positioning.

3. COMPANY PROFILE

Equifax is a data, analytics and technology company in the Industrials sector, classed under Consulting Services. It runs three segments: Workforce Solutions, U.S. Information Solutions (USIS) and International. Workforce Solutions provides income and employment verification and related payroll and HR compliance services. The market capitalisation is $21.99bn.

Recent results show steady growth. The first quarter brought record revenue, with U.S. mortgage up 38% before rates rose (company release, April 21). Second-quarter revenue rose 11% and the AI cost-reduction target doubled to $150m (company release, July 21). In the third quarter, Equifax returned $158m to shareholders, and year-to-date government contract signings exceeded $550m in annual contract value (Investing.com). Benzinga reports that management reaffirmed long-term targets of 7–10% organic growth and at least 50bp of annual EBITDA margin expansion.

4. DEEP DIVE ANALYSIS

Do fundamentals justify the move? The profit and margin evidence supports a re-rating from depressed levels. Net income grew 32%, mortgage revenue grew 15% in a weak market, and cost savings came in ahead of plan. The stock closed at $148.80 twenty sessions ago and at a 52-week low of $137.01 on September 30, so a good part of the rally recovers ground lost to pre-earnings pessimism. The forward P/E of 19.5 against a trailing 28.4 shows the market pricing in earnings growth.

The revenue guidance gives the sceptics their case. The lower fourth-quarter range and the trimmed full-year midpoint show the top line decelerating, and TIKR says management does not expect the mortgage market to recover before year-end.

Analyst reaction. Target changes moved sharply upward after the report:

Before earnings, targets had gone the other way: Morgan Stanley cut from $225 to $205 (October 13), RBC from $194 to $177 (October 16), Mizuho from $210 to $185 (October 19), and Oppenheimer downgraded to Perform on October 16, citing mortgage exposure of roughly 20–22% of revenue. MarketBeat reports 15 Buy and 6 Hold ratings with an average target of $200. Sources quote consensus between $196.38 and $200, so the close of $187.14 sits below every version.

Peers. Industrial names fell over the same period: GEV -10.69%, VRT -8.92%, BE -7.84%, GE -5.92%, CAT -4.29% and BA -0.63%. These are poor comparables for a data business, but they show Equifax rising against a weak tape.

Bull case. Margin expansion from AI savings continues, the credit-scoring model gains share, the Círculo de Crédito acquisition adds growth with more than $1.5bn of financial capacity, and a mortgage recovery adds upside to a business already growing.

Bear case. Revenue guidance moved down, mortgage stays weak into year-end, and a 25.77% gain over 20 sessions has already priced in much of the good news. Part of the October 22 gain came from sympathy buying and a single upgrade.

5. TECHNICAL SNAPSHOT

The close of $187.14 is the highest in the daily table and sits above both the 50-day average of $166.89 and the 200-day average of $177.30, so the stock has recovered both trend lines within a week. It remains well below the 52-week high of $236.24 and is 36.59% above the 52-week low of $137.01. Volume on October 22 was 2,741,300, which is 1.66x the 50-session average of 1,651,650, and October 20 drew 3,986,100, so buyers have participated heavily. With the latest close the highest in the table, no nearer resistance level is available from the closes; the $200 level matches the Argus and MarketBeat targets.

6. RISK FACTORS

• Mortgage market weakness persisting beyond year-end, with mortgage exposure of roughly 20–22% of revenue according to Oppenheimer.
• Fourth-quarter revenue guidance of $1.605–1.635bn sits below the roughly $1.68bn analysts wanted, and a miss against even the lower range would hurt.
• The rally has been fast, and the first leg on October 15 has no identified cause, so part of the gain may lack fundamental backing.
• Sector sentiment: Barclays cited negative sentiment across business services in a target cut, and TransUnion's sympathy move shows the shares trade with the group.
• Guidance details are partly unverified: one headline reported a narrowed EPS range of $8.45–8.55, while other sources say the $8.50 midpoint was kept.

Dated catalysts: the Círculo de Crédito acquisition is expected to close in the fourth quarter of 2026, and fourth-quarter results are expected in early February 2027 (TIKR). The research found no other dated events.

7. ACTIONABLE OUTLOOK

Short term (1-2 weeks). After a 16.05% weekly gain, the shares are extended, with the 1.66x volume on the latest session showing active demand. Further target raises from the firms that cut ahead of earnings would support the price, while a slip in the broader market, which fell 1.21% on October 22, would pressure it. The $176.54 close on October 20 is the nearest reference point for a pullback.

Medium term (1-3 months). The stock must hold the 200-day average of $177.30 to keep the recovery intact, and progress towards the $200 consensus target depends on evidence that margins keep expanding while mortgage stays soft. The Círculo de Crédito closing is the one dated event in the window.

Long term. The thesis is unchanged. Management reaffirmed 7–10% organic growth and at least 50bp of annual EBITDA margin expansion, and the third-quarter results gave evidence for the margin part of that. The lower 2026 revenue midpoint is the one item to monitor. This report is analysis only and not personal financial advice.